Ml. Ricketts et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF TYPE-1 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN HUMAN TISSUES, The Journal of clinical endocrinology and metabolism, 83(4), 1998, pp. 1325-1335
Two isozymes of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) cat
alyze the interconversion of hormonally active cortisol to inactive co
rtisone. Activity and messenger ribonucleic acid studies indicate that
type 1 11 beta HSD (11 beta HSD1) is expressed in glucocorticoid targ
et tissues such as liver, gonad, and cerebellum, where it regulates th
e exposure of cortisol to glucocorticoid receptors. To further underst
and the role of 11 beta HSD1 in human tissues, we have studied the loc
alization of this isozyme using an antibody raised in sheep against am
ino acids 19-33 of human 11 beta HSD1. Western blot analyses indicated
that the immunopurified antibody recognized a band of approximately 3
4 kDa in human liver and decidua. Immunoperoxidase studies on liver, a
drenal, ovary, decidua, and adipose tissue indicated positive cytoplas
mic staining for 11 beta HSD1. 11 beta HSD1 immunoreactivity was obser
ved more intensely around the hepatic central vein, with no staining a
round the portal vein, hepatic artery, or bile ducts. No staining for
11 beta HSD1 was observed in the adrenal medulla, but 11 beta HSD1-imm
unoreactive protein was observed in all three zones of the adrenal cor
tex, with the most intense staining in the zona reticularis > zona glo
merulosa > zona fasciculata. In the human ovary, immunoreactivity was
observed in the developing oocyte and the luteinized granulosa cells o
f the corpus luteum. No staining was observed in granulosa cells, thec
al cells, or ovarian stroma, which contrasted with the marked expressi
on of 11 beta HSD2 in the granulosa cell layer. Sections of human deci
dua showed high expression of 11 beta HSD1 in decidual cells. In oment
al adipose tissue, 11 beta HSD1 immunoreactivity was observed in both
stromal and adipocyte cells. Immunohistochemical localization of 11 be
ta HSD1 in human liver, adrenal, ovary, decidua, and adipose tissue us
ing this novel antiserum provides us with a tool to investigate the ro
le of this isozyme in modulating glucocorticoid hormone action within
these tissues.